Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1199-1204

  Santibáñez, Juan Francisco ^a   Navarro, Alberto ^a   Martínez, Jorge ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Genistein; Invasion; Metastasis; Prostate

Indexed keywords

FLAVONE; GENISTEIN; PHOSPHOPROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; CELL DIVISION; GELATINASES; GENISTEIN; HUMANS; ISOFLAVONES; MALE; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 1842415950     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Armstrong B and Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15: 617-631, 1975.
2. I.A.R.C: Cancer incidence in five continents. Vol 4, Lyon France IARC, 1982.
3. Adlcrcreutz H: Lignons and phytoestrogen. Possible preventive role in cancer. In: Frontiers in gastrointestinal research. Rozen P. de. vol 14 pp 165-176. S. Karger, Basel. Switzerland, 1988.
4. Barnes S: Effect of genistein on in vitro and in nvo models of cancer. J Nutr 125: 777s-783s. 1995.
5. Barnes S, Peterson TG, Grubbs C and Setchell KDR: Potential role of dietary isoflavones in the prevention of cancer. In: Diet and cancer: Markers, Prevention and Treatment (Jacobs M.M., ed.) pp 135-148 Planum Press, NewYork, 1994.
6. Fotsis T, Pepper M, Adlercreutz H, Fleishmann G, Hase T, Montesano R and Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci (USA) 90: 2690-2694, 1993.
7. Mueller SC, Yeh Y and Chen WT: Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J Cell Biol 119: 1309-1325, 1992.
8. Markovits J, Linassier C, Fosse Ph, Couprie J, Pierre J, Jacquemin-Cablon A, Saucier JM. Le Pecq JB and Larsen A: Inhibitory effects of the tyrosine kinase inhibitor Genistein on mammalian DNA topoisomerase. Cancer Res 49: 5111-5117, 1989.
9. Pagliacci MC, Spinozi F, Migliorati G, Fumu G, Smacchia M, Grignani F, Riccadi C and Nicolctti I: Genistein inhibits tumor cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further piffall in the use of MTT assay for evaluating cell growth and survival. Hur J Cancer 29A: 1573-1577, 1993.
10. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3) Inves Urol 17: 16-23, 1989.
11. Stone KR, Mickey DD, Wunderly H, Mickey GH and Paulson DF: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281, 1978.
12. Horoszewics JS, Leong SS, Kawinski E, Karr JP Rosenthal H, Chu MT, Mirand EA and Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1991.
13. Santibáñez JF, Maccioni RB and Martinez J: The secretion of urokinase-likc plasminogen activator is inhibited by microtubule-interacting drugs. Cell Biochem Funct 13: 217-225, 1995.
14. McGadey: A tetrazolium method for non-specific alkaline phosphatase. Histochemie 23: 180-184, 1970.
15. MacKay AR, Harzler JL, Pelina MD and Thorgeisson UP: Studies on the ability of 65 kDa and 92 kDa tumor cell gelatinases to degrade type IV collagen. J Biol Chem. 265: 21929-21934, 1990.
16. Carmichel J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
17. Hoosein NM, Boyd DD, Hollas WJ, Mazar A, Henkin J and Chung LWK: Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Cancer Communication 3: 255-264, 1991.
18. Chiarodo A: National Cancer Institute roundtable on prostate cancer: Future research directions. Cancer Res 51: 2498-2505, 1991.
19. Yagoda A. and Petrylak D: Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer 71: 1098-1109. 1993.
20. Yanagihara K, Ito A, Toge T and Numoto M: Antiproliferative effects of isoflavones on human cancer cell lines established from gastrointestinal tract. Cancer Res 53: 5815-5821, 1993.
21. Peterson G: Evaluation of the biochemical targets of Gesnistein in tumor cells. J Nutr 125: 784s-789s, 1995.
22. Naik HR, Lehr JE and Pienta KJ: An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Res 14: 2617-2620, 1994.
23. Okura A, Arakawa H, Oka H, Yoshinari T and Monden Y: Effect of Gonistein on topoisomerase activity and on growth of [Val 12] Haras-transformed NIH 3T3 cells. Biochem and Biophys Res Comm 157: 183-189, 1988.